Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Autoimmune Disorders

  Free Subscription


Articles published in J Rheumatol

Retrieve available abstracts of 244 articles:
HTML format



Single Articles


    September 2021
  1. LIEBER SB, Nahid M, Paget S, Berman JR, et al
    Evaluation of a Patient-Reported Frailty Tool in Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Sep 1. pii: jrheum.201466. doi: 10.3899/jrheum.201466.
    PubMed     Abstract available


    August 2021
  2. WANG X, Hefton A, Ni K, Ukadike KC, et al
    Autoantibodies against unmodified and citrullinated human endogenous retrovirus K envelope protein in rheumatoid arthritis patients.
    J Rheumatol. 2021 Aug 1. pii: jrheum.201492. doi: 10.3899/jrheum.201492.
    PubMed     Abstract available


    June 2021
  3. SMITHERMAN EA, Cron RQ
    Hyperferritinemia Wins Again: Defining Macrophage Activation Syndrome in Pediatric Systemic Lupus Erythematosus.
    J Rheumatol. 2021 Jun 15. pii: jrheum.210024. doi: 10.3899/jrheum.210024.
    PubMed     Abstract available


  4. AL AWQATI MZ, Sluzevich JC, Berianu F
    Ulcerative Paraneoplastic Dermatomyositis in the Setting of Positive Transcriptional Intermediary Factor 1-gamma Antibody.
    J Rheumatol. 2021 Jun 15. pii: jrheum.200399. doi: 10.3899/jrheum.200399.
    PubMed     Abstract available


  5. VILLIGER PM
    Giant Cell Arteritis: Real-life Experience.
    J Rheumatol. 2021 Jun 1. pii: jrheum.210334. doi: 10.3899/jrheum.210334.
    PubMed     Abstract available


    May 2021
  6. HAZLEWOOD GS, Pardo J, Barnabe C, Schieir O, et al
    Canadian Rheumatology Association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases.
    J Rheumatol. 2021 May 15. pii: jrheum.210288. doi: 10.3899/jrheum.210288.
    PubMed     Abstract available


  7. RAHMAN A
    Why Do Patients With Systemic Lupus Erythematosus Suffer Pain?
    J Rheumatol. 2021 May 1. pii: jrheum.210057. doi: 10.3899/jrheum.210057.
    PubMed     Abstract available


    April 2021
  8. DIAZ T, Dominguez D, Jaeggi E, Knight A, et al
    Ethnicity and Neonatal Lupus Erythematosus Manifestations Risk in a Large Multi-Ethnic Cohort.
    J Rheumatol. 2021 Apr 1. pii: jrheum.201338. doi: 10.3899/jrheum.201338.
    PubMed     Abstract available


  9. LANGLEBEN D, Berkson L, Chartrand S
    Selexipag Therapy for Raynaud Phenomenon-induced Severe Digital Ischemia in Intravenous Epoprostenol Responders With Connective Tissue Disease.
    J Rheumatol. 2021;48:616-617.
    PubMed    


  10. JAYNE D
    Antineutrophil Cytoplasmic Antibody-associated Vasculitis Management 2020: Where Are We Now?
    J Rheumatol. 2021;48:479-481.
    PubMed    


  11. SCHNEIDER J, Venhoff N, Walz G
    Ruptured Intrarenal Arterial Aneurysm in a Patient With Granulomatosis With Polyangiitis.
    J Rheumatol. 2021;48:615.
    PubMed    


  12. GKROUZMAN E, Sevim E, Finik J, Andrade D, et al
    Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository.
    J Rheumatol. 2021;48:541-547.
    PubMed     Abstract available


  13. MENDEL A, Ennis D, Go E, Bakowsky V, et al
    CanVasc Consensus Recommendations for the Management of Antineutrophil Cytoplasm Antibody-associated Vasculitis: 2020 Update.
    J Rheumatol. 2021;48:555-566.
    PubMed     Abstract available


  14. LUO Y, Xu J, Jiang C, Krittanawong C, et al
    Trends in the Inpatient Burden of Coronary Artery Disease in Granulomatosis With Polyangiitis: A Study of a Large National Dataset.
    J Rheumatol. 2021;48:548-554.
    PubMed     Abstract available


  15. MALLER J, Fox E, Park KT, Paul SS, et al
    Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis.
    J Rheumatol. 2021;48:567-574.
    PubMed     Abstract available


    March 2021
  16. RUSSELL AS
    The Variability of Antinuclear Antibody Testing.
    J Rheumatol. 2021 Mar 15. pii: jrheum.210039. doi: 10.3899/jrheum.210039.
    PubMed     Abstract available


  17. MOHAMMAD AJ, Turkiewicz A, Stamatis P, Turesson C, et al
    Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis - A Population-Based Study.
    J Rheumatol. 2021 Mar 1. pii: jrheum.201131. doi: 10.3899/jrheum.201131.
    PubMed     Abstract available


  18. ROSSIDES M
    Stroke is Different in Systemic Lupus Erythematosus: Implications for Survival and Functionality.
    J Rheumatol. 2021 Mar 1. pii: jrheum.201209. doi: 10.3899/jrheum.201209.
    PubMed     Abstract available


  19. BERTI A, Specks U
    The Survival of Patients With Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
    J Rheumatol. 2021;48:314-317.
    PubMed    


  20. ROBERTSON AD
    What It Means to Me to Have Juvenile Arthritis: One Patient's Definition.
    J Rheumatol. 2021;48:470.
    PubMed    


  21. TANG S, Li X, Zhao KY, Zhou Q, et al
    Clinical Characteristics and Prognostic Analysis of Microscopic Polyangiitis With Diffuse Alveolar Hemorrhage.
    J Rheumatol. 2021;48:410-416.
    PubMed     Abstract available


  22. ONO N, Inoue Y, Miyamura T, Ueda N, et al
    The Association of Airway Comorbidities With the Clinical Phenotypes and Outcomes of Patients With Antineutrophil Cytoplasmic Autoantibody-associated Vasculitis.
    J Rheumatol. 2021;48:417-425.
    PubMed     Abstract available


    February 2021
  23. CLEMENT J, Duffau P, Constans J, Schaeverbeke T, et al
    Real-world risk of relapse of giant cell arteritis treated with tocilizumab: A retrospective analysis of 43 patients.
    J Rheumatol. 2021 Feb 15. pii: jrheum.200952. doi: 10.3899/jrheum.200952.
    PubMed     Abstract available


  24. VYNCKIER J, Demeestere J, Lambert J
    Black-blood Magnetic Resonance Imaging in Giant Cell Arteritis.
    J Rheumatol. 2021;48:301-302.
    PubMed    


  25. KORKUS D, Gazitt T, Cohen AD, Feldhamer I, et al
    Increased Prevalence of Systemic Lupus Erythematosus Comorbidity in Patients With Psoriatic Arthritis: A Population-based Case-control Study.
    J Rheumatol. 2021;48:207-213.
    PubMed     Abstract available


  26. PETRI M, Barr E, Magder LS
    Risk of Renal Failure Within 10 or 20 Years of Systemic Lupus Erythematosus Diagnosis.
    J Rheumatol. 2021;48:222-227.
    PubMed     Abstract available


  27. WALSCHEID K, Glandorf K, Rothaus K, Niewerth M, et al
    Enthesitis-related Arthritis: Prevalence and Complications of Associated Uveitis in Children and Adolescents From a Population-based Nationwide Study in Germany.
    J Rheumatol. 2021;48:262-269.
    PubMed     Abstract available


    January 2021
  28. AGARWAL S
    Update on Sweet Syndrome in Eosinophilic Granulomatosis With Polyangiitis.
    J Rheumatol. 2021;48:151.
    PubMed    


    December 2020
  29. ORLANDI M, Landini N, Bruni C, Colagrande S, et al
    Infection or autoimmunity? The clinical challenge of interstitial lung disease in systemic sclerosis during COVID 19 pandemic.
    J Rheumatol. 2020 Dec 1. pii: jrheum.200832. doi: 10.3899/jrheum.200832.
    PubMed     Abstract available


  30. GERSTEIN M, Borgia RE, Dominguez D, Feldman BM, et al
    Predicting macrophage activation syndrome (MAS) in childhood-onsetsystemic lupus erythematosus (cSLE) patients at diagnosis.
    J Rheumatol. 2020 Dec 1. pii: jrheum.200292. doi: 10.3899/jrheum.200292.
    PubMed     Abstract available


    November 2020
  31. GEORGE M, Venkatachalam S, Banerjee S, Baker JF, et al
    Concerns, healthcare use, and treatment interruptions in patients with common autoimmune rheumatic diseases during the COVID-19 pandemic.
    J Rheumatol. 2020 Nov 15. pii: jrheum.201017. doi: 10.3899/jrheum.201017.
    PubMed     Abstract available


  32. ROSINA S, Varnier GC, Pistorio A, Pilkington C, et al
    Development and testing of reduced versions of the MMT-8 in juvenile dermatomyositis.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200543. doi: 10.3899/jrheum.200543.
    PubMed     Abstract available


  33. BATU ED, Kaya Akca U, Pac Kisaarslan A, Sag E, et al
    The performances of the ACR 1997, SLICC 2012, and EULAR/ACR 2019 classification criteria in pediatric systemic lupus erythematosus.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200871. doi: 10.3899/jrheum.200871.
    PubMed     Abstract available


  34. LAMBERS WM, Westra J, Bootsma H, de Leeuw K, et al
    Hydroxychloroquine suppresses interferon-inducible genes and B-cell activating factor in patients with incomplete and new onset systemic lupus erythematosus.
    J Rheumatol. 2020 Nov 15. pii: jrheum.200726. doi: 10.3899/jrheum.200726.
    PubMed     Abstract available


  35. ZHANG B, Chi H, Su Y
    Near Tetraploidy in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:1725-1726.
    PubMed    


  36. FAYE AS, Lee KE, Laszkowska M, Kim J, et al
    Risk of Adverse Outcomes in Hospitalized Patients with Autoimmune Disease and COVID-19: A Matched Cohort Study from New York City.
    J Rheumatol. 2020 Nov 1. pii: jrheum.200989. doi: 10.3899/jrheum.200989.
    PubMed     Abstract available


  37. GAMWELL KL, Hommel KA
    Comprehensive Care in Pediatric Rheumatic Diseases: A Multifaceted Challenge.
    J Rheumatol. 2020;47:1603-1605.
    PubMed    


    October 2020
  38. KIM JW, Jung JY, Kim HA, Yang JI, et al
    Lupus Low Disease Activity State achievement is important for reducing adverse outcomes in pregnant patients with systemic lupus erythematosus.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200802. doi: 10.3899/jrheum.200802.
    PubMed     Abstract available


  39. DOMINGUEZ D, Kamphuis S, Beyene J, Wither J, et al
    Relationship between Genetic Risk and Age of Diagnosis of Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200002. doi: 10.3899/jrheum.200002.
    PubMed     Abstract available


  40. MEHTA P, Sattui SE, van der Geest K, Brouwer E, et al
    Giant cell arteritis and COVID-19: similarities and discriminators, a systematic literature review.
    J Rheumatol. 2020 Oct 15. pii: jrheum.200766. doi: 10.3899/jrheum.200766.
    PubMed     Abstract available


    September 2020
  41. TROUNG L, Pourzand L, Volkmann ER
    Covid-19 in Patients with Connective Tissue Disease-Related Interstitial Lung Disease.
    J Rheumatol. 2020 Sep 15. pii: jrheum.201064. doi: 10.3899/jrheum.201064.
    PubMed     Abstract available


  42. SALAMA AD, Caplin B
    Lupus Nephritis and Chronic Kidney Disease.
    J Rheumatol. 2020;47:1303-1304.
    PubMed    


  43. TSELIOS K, Gladman DD, Taheri C, Su J, et al
    Factors Associated with Rapid Progression to End Stage Kidney Disease in Lupus Nephritis.
    J Rheumatol. 2020 Sep 1. pii: jrheum.200161. doi: 10.3899/jrheum.200161.
    PubMed     Abstract available


  44. TSOI LK, Mok CC, Man BL, Fu YP, et al
    Imaging pattern and outcome of stroke in patients with systemic lupus erythematosus: a case-control study.
    J Rheumatol. 2020 Sep 1. pii: jrheum.200664. doi: 10.3899/jrheum.200664.
    PubMed     Abstract available


    August 2020
  45. HIRAKI LT
    APOL1 Gene - Implications for Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:1155-1157.
    PubMed    


    July 2020
  46. ALMAGHLOUTH I, Pullenayegum E, Gladman DD, Urowitz MB, et al
    Propensity Score Methods in Rare Disease. A Demonstration Using Observational Data in Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Jul 1. pii: jrheum.200254. doi: 10.3899/jrheum.200254.
    PubMed     Abstract available


  47. MURIMI IB, Lin DH, Kan H, Tierce J, et al
    Health Care Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States.
    J Rheumatol. 2020 Jul 1. pii: jrheum.191187. doi: 10.3899/jrheum.191187.
    PubMed     Abstract available


    June 2020
  48. QUEVEDO-ABELEDO JC, Sanchez-Perez H, Tejera-Segura B, de Armas-Rillo L, et al
    Higher Prevalence and Degree of Insulin Resistance in Patients with Rheumatoid Arthritis than in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Jun 15. pii: jrheum.200435. doi: 10.3899/jrheum.200435.
    PubMed     Abstract available


  49. FAVALLI EG, Agape E, Caporali R
    Are patients with systemic lupus erythematosus at increased risk of severe COVID-19?
    J Rheumatol. 2020 Jun 1. pii: jrheum.200723. doi: 10.3899/jrheum.200723.
    PubMed     Abstract available


  50. PESCHKEN CA
    Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.
    J Rheumatol. 2020;47:787-790.
    PubMed    


  51. SO H, Mak JWY, Tam LS
    No Systemic Lupus Erythematosus with COVID-19 in Hong Kong: The Effect of Masking?
    J Rheumatol. 2020 Jun 1. pii: jrheum.200605. doi: 10.3899/jrheum.200605.
    PubMed     Abstract available


  52. STOUSTRUP P, Twilt M, Herlin T
    Systemic Treatment for Temporomandibular Joint Arthritis in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2020;47:793-795.
    PubMed    


    May 2020
  53. STAMATIS P, Turkiewicz A, Englund M, Jonsson G, et al
    Infections are associated with increased risk of giant cell arteritis - a population-based case-control study from Southern Sweden.
    J Rheumatol. 2020 May 15. pii: jrheum.200211. doi: 10.3899/jrheum.200211.
    PubMed     Abstract available


  54. CHEN C, Yao B, Yan M, Su K, et al
    The plight of patients with lupus nephritis in Wuhan, China.
    J Rheumatol. 2020 May 8. pii: jrheum.200452. doi: 10.3899/jrheum.200452.
    PubMed     Abstract available


  55. SILVA-DIAZ M, Freire Gonzalez M, Romero TH
    Pulmonary Alveolar Proteinosis in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2020;47:779-780.
    PubMed    


  56. TURK MA, Hayworth JL, Nevskaya T, Pope JE, et al
    Ocular manifestations in rheumatoid arthritis, connective tissue disease and vasculitis: a systematic review and meta-analysis.
    J Rheumatol. 2020 May 1. pii: jrheum.190768. doi: 10.3899/jrheum.190768.
    PubMed     Abstract available


  57. KWAK SG, Par SH, Kim JY
    Incidence and prevalence of juvenile systemic lupus erythematosus in Korea: data from the national health claims database 2017.
    J Rheumatol. 2020 May 1. pii: jrheum.191186. doi: 10.3899/jrheum.191186.
    PubMed     Abstract available


    April 2020
  58. FAVALLI EG, Agape E, Caporali R
    Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis.
    J Rheumatol. 2020 Apr 25. pii: jrheum.200507. doi: 10.3899/jrheum.200507.
    PubMed     Abstract available


  59. ERNSTE FC, Chong C, Crowson CS, Kermani TA, et al
    Functional Index-3: A Valid and Reliable Functional Outcome Assessment Measure in Dermatomyositis and Polymyositis Patients.
    J Rheumatol. 2020 Apr 15. pii: jrheum.191374. doi: 10.3899/jrheum.191374.
    PubMed     Abstract available


  60. TSELIOS K, Gladman DD, Su J, Urowitz MB, et al
    Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable?
    J Rheumatol. 2020 Apr 1. pii: jrheum.191064. doi: 10.3899/jrheum.191064.
    PubMed     Abstract available


  61. TAKEUCHI T, Wakasugi N, Makino H
    Long-term safety and effectiveness of tacrolimus in lupus nephritis patients: 5- year interim post-marketing surveillance study in Japan (TRUST).
    J Rheumatol. 2020 Apr 1. pii: jrheum.191008. doi: 10.3899/jrheum.191008.
    PubMed     Abstract available


  62. LIU K, Tomlinson G, Reed AM, Huber AM, et al
    Pilot study of the juvenile dermatomyositis consensus treatment plans: a CARRA Registry study.
    J Rheumatol. 2020 Apr 1. pii: jrheum.190494. doi: 10.3899/jrheum.190494.
    PubMed     Abstract available


  63. UROWITZ MB, Gladman DD, Ibanez D, Su J, et al
    Impact of disease activity on organ damage progression in systemic lupus erythematosus: University of Toronto Lupus Clinic Cohort.
    J Rheumatol. 2020 Apr 1. pii: jrheum.190259. doi: 10.3899/jrheum.190259.
    PubMed     Abstract available


    March 2020
  64. CLAIRMAN H, Dover S, Whitney K, Marcuz JA, et al
    Correlation of a Modified Disease Activity Score with the Validated Original Disease Activity Score in Patients with Juvenile Dermatomyositis.
    J Rheumatol. 2020 Mar 15. pii: jrheum.191255. doi: 10.3899/jrheum.191255.
    PubMed     Abstract available


  65. NAIDES SJ, Genzen JR, Abel G, Bashleben C, et al
    Antinuclear Antibodies (ANA) Testing Method Variability: A Survey of Participants in the College of American Pathologists' (CAP) Proficiency Testing Program.
    J Rheumatol. 2020 Mar 15. pii: jrheum.190933. doi: 10.3899/jrheum.190933.
    PubMed     Abstract available


  66. HOGE C, Bowling CB, Lim SS, Drenkard C, et al
    Association of Poverty Income Ratio with Physical Functioning in a Cohort of Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2020 Mar 1. pii: jrheum.190991. doi: 10.3899/jrheum.190991.
    PubMed     Abstract available


    February 2020
  67. MOISEEV S, Zykova A, Bulanov N, Gitel E, et al
    Is There a Role for LAMP-2 Autoantibodies in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis?
    J Rheumatol. 2020 Feb 15. pii: jrheum.191082. doi: 10.3899/jrheum.191082.
    PubMed     Abstract available


  68. WARD JM, Hess JN, Davis LS
    Targetoid-like Lesions in the Setting of Systemic Lupus Erythematosus: A Case of Rowell Syndrome.
    J Rheumatol. 2020;47:298-299.
    PubMed    


  69. CHANG JC, Knight AM, Lawson EF
    Patterns of Health Care Utilization and Medication Adherence Among Youth with Systemic Lupus Erythematosus During Transfer from Pediatric to Adult Care.
    J Rheumatol. 2020 Feb 1. pii: jrheum.191029. doi: 10.3899/jrheum.191029.
    PubMed     Abstract available


    January 2020
  70. CANNON L, Dvergsten J, Stingl C
    Juvenile Dermatomyositis and Development of Malignancy: 2 Case Reports and a Literature Review.
    J Rheumatol. 2020 Jan 15. pii: jrheum.190929. doi: 10.3899/jrheum.190929.
    PubMed     Abstract available


    December 2019
  71. MOORE S, Juo HH, Nielsen CT, Tyden H, et al
    Neutrophil extracellular traps identify patients at risk of increased disease activity and cardiovascular comorbidity in systemic lupus erythematosus.
    J Rheumatol. 2019 Dec 15. pii: jrheum.190875. doi: 10.3899/jrheum.190875.
    PubMed     Abstract available


  72. BEN-SHABAT N, Tiosano S, Shovman O, Comaneshter D, et al
    Mortality among patients with giant-cell arteritis: A large-scale population-based cohort study.
    J Rheumatol. 2019 Dec 15. pii: jrheum.190927. doi: 10.3899/jrheum.190927.
    PubMed     Abstract available


  73. CHUA MHY, Ng IAT, Cheung MWL, Mak A, et al
    Association Between Cigarette Smoking and Systemic Lupus Erythematosus - an Updated Multivariate Bayesian Metaanalysis.
    J Rheumatol. 2019 Dec 1. pii: jrheum.190733. doi: 10.3899/jrheum.190733.
    PubMed     Abstract available


  74. DAHAL LN, Barker RN, Ward FJ
    The Soluble Isoform of CTLA-4 Correlates with Interferon-alpha Activity in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Dec 1. pii: jrheum.190678. doi: 10.3899/jrheum.190678.
    PubMed     Abstract available


    November 2019
  75. VAJGEL G, Lima SC, Santana DJS, Oliveira CBL, et al
    A single APOL1 nephropathy variant increases risk of advanced lupus nephritis in Brazilians.
    J Rheumatol. 2019 Nov 15. pii: jrheum.190684. doi: 10.3899/jrheum.190684.
    PubMed     Abstract available


  76. CHEN SK, Barbhaiya M, Solomon DH, Guan H, et al
    Atrial Fibrillation/Flutter Hospitalizations among U.S. Medicaid Recipients with and without Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Nov 1. pii: jrheum.190502. doi: 10.3899/jrheum.190502.
    PubMed     Abstract available


  77. MORONI L, Restovic G, Cervera R, Espinosa G, et al
    Economic Impact Analysis of the Use of Anti-DFS70 Antibody Test In Patients with Undifferentiated Systemic Autoimmune Disease Symptoms.
    J Rheumatol. 2019 Nov 1. pii: jrheum.190533. doi: 10.3899/jrheum.190533.
    PubMed     Abstract available



  78. More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:1548.
    PubMed    


    October 2019
  79. COUTURE P, Bachmeyer C, Monfort JB
    Koebner Phenomenon in Dermatomyositis after Subcutaneous Methotrexate Injections.
    J Rheumatol. 2019;46:1350.
    PubMed    


  80. MORAND EF, Golder V
    Treat-to-target Endpoint Definitions in Systemic Lupus Erythematosus: More Is Less?
    J Rheumatol. 2019;46:1256-1258.
    PubMed    


    September 2019
  81. RUACHO G, Kvarnstrom M, Zickert A, Oke V, et al
    Sjogren's syndrome in Systemic Lupus Erythematosus - a subset characterized by a systemic inflammatory state.
    J Rheumatol. 2019 Sep 15. pii: jrheum.190250. doi: 10.3899/jrheum.190250.
    PubMed     Abstract available


  82. BOLLHALDER A, Patcas R, Eichenberger M, Muller L, et al
    Magnetic Resonance Imaging Follow-up of Temporomandibular Joint Inflammation, Deformation and Mandibular Growth in Juvenile Idiopathic Arthritis Patients on Systemic Treatment.
    J Rheumatol. 2019 Sep 15. pii: jrheum.190168. doi: 10.3899/jrheum.190168.
    PubMed     Abstract available


  83. SMITH V, Distler O, Cutolo M
    Might Nailfold Capillaroscopy Be a "Proxy" for Lung Involvement in Connective Tissue Diseases?
    J Rheumatol. 2019;46:1061-1063.
    PubMed    


  84. MUKWIKWI ER, Pineau CA, Vinet E, Clarke AE, et al
    Retinal Complications in Systemic Lupus Erythematosus Patients Treated with Antimalarial Drugs.
    J Rheumatol. 2019 Sep 1. pii: jrheum.181102. doi: 10.3899/jrheum.181102.
    PubMed     Abstract available


  85. SMITHERMAN EA, Huang B, Furnier A, Taylor J, et al
    Quality of care in childhood-onset systemic lupus erythematosus: Report of an intervention to improve cardiovascular and bone health screening.
    J Rheumatol. 2019 Sep 1. pii: jrheum.190295. doi: 10.3899/jrheum.190295.
    PubMed     Abstract available


    August 2019
  86. KISHI T, Chipman J, Evereklian M, Nghiem K, et al
    Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis.
    J Rheumatol. 2019 Aug 1. pii: jrheum.181275. doi: 10.3899/jrheum.181275.
    PubMed     Abstract available


    July 2019
  87. BREKKE LK, Fevang BS, Diamantopoulos AP, Assmus J, et al
    Risk of cancer in 767 patients with giant cell arteritis in western Norway: a retrospective cohort with matched controls.
    J Rheumatol. 2019 Jul 15. pii: jrheum.190147. doi: 10.3899/jrheum.190147.
    PubMed     Abstract available


  88. DE LUCA G, Campochiaro C, Dagna L
    Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: The Role of Endomyocardial Biopsy.
    J Rheumatol. 2019 Jul 1. pii: jrheum.190078. doi: 10.3899/jrheum.190078.
    PubMed     Abstract available


  89. LI C, Zhao J, Zhao Y
    Hepatic Infarction Caused by Antiphospholipid Syndrome Secondary to Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:755-756.
    PubMed    


    June 2019
  90. STOJAN G, Magder LS, Petri M
    Blood Pressure Variability and Age-related Blood Pressure Patterns in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Jun 15. pii: jrheum.181131. doi: 10.3899/jrheum.181131.
    PubMed     Abstract available


  91. WONG PC, Lee G, Sedie AD, Hanova P, et al
    Musculoskeletal Ultrasound in Systemic Lupus Erythematosus: Systematic Literature Review by the Lupus Task Force of the OMERACT Ultrasound Working Group.
    J Rheumatol. 2019 Jun 15. pii: jrheum.181087. doi: 10.3899/jrheum.181087.
    PubMed     Abstract available


  92. LI YC, Chang DM, Lu CC
    Montreal Cognitive Assessment and Magnetic Resonance Imaging Identify Cognitive Impairment in Young Patients with Neuropsychiatric Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:653.
    PubMed    


  93. STAMATIS P, Turesson C, Willim M, Nilsson JA, et al
    Malignancies In Giant Cell Arteritis: A Population-Based Cohort Study.
    J Rheumatol. 2019 Jun 1. pii: jrheum.190236. doi: 10.3899/jrheum.190236.
    PubMed     Abstract available


    May 2019
  94. FELDMAN CH, Malspeis S, Leatherwood C, Kubzansky L, et al
    Association of Childhood Abuse with Incident Systemic Lupus Erythematosus in Adulthood in a Longitudinal Cohort of Women.
    J Rheumatol. 2019 May 15. pii: jrheum.190009. doi: 10.3899/jrheum.190009.
    PubMed     Abstract available


  95. FUJISAWA T, Hozumi H, Yasui H, Suzuki Y, et al
    Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody-positive Dermatomyositis-associated Interstitial Lung Disease.
    J Rheumatol. 2019 May 15. pii: jrheum.180825. doi: 10.3899/jrheum.180825.
    PubMed     Abstract available


  96. BRUSCHI M, Bonanni A, Petretto A, Vaglio A, et al
    Neutrophil Extracellular Traps (NETs) profiles in patients with incident SLE and lupus nephritis.
    J Rheumatol. 2019 May 15. pii: jrheum.181232. doi: 10.3899/jrheum.181232.
    PubMed     Abstract available


  97. ORMSETH MJ, Solus JF, Sheng Q, Ye F, et al
    Development and Validation of a microRNA Panel to Differentiate between Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus and Controls.
    J Rheumatol. 2019 May 15. pii: jrheum.181029. doi: 10.3899/jrheum.181029.
    PubMed     Abstract available


  98. BROUWER E, VAN DER Geest KSM, Sandovici M
    Methotrexate in Giant Cell Arteritis Deserves a Second Chance - A High-dose Methotrexate Trial Is Needed.
    J Rheumatol. 2019;46:453-454.
    PubMed    


    April 2019
  99. LEGGE A, Kirkland S, Rockwood K, Andreou P, et al
    Construction of a frailty index as a novel health measure in systemic lupus erythematosus.
    J Rheumatol. 2019 Apr 15. pii: jrheum.181338. doi: 10.3899/jrheum.181338.
    PubMed     Abstract available


  100. RUA-FIGUEROA I, Lopez-Longo F, Del Campo V, Galindo-Izquierdo M, et al
    Bacteremia in systemic lupus erythematosus patients from RELESSER: risk factors, clinical and microbiological characteristics and outcomes.
    J Rheumatol. 2019 Apr 15. pii: jrheum.180882. doi: 10.3899/jrheum.180882.
    PubMed     Abstract available


  101. MILLS BS, Dao KH, Tecson KM, Fishman E, et al
    Perceptions of Pregnancy and Lactation from the Pregnancy and Lactation Autoimmune Network (PLAN) Registry.
    J Rheumatol. 2019 Apr 1. pii: jrheum.181067. doi: 10.3899/jrheum.181067.
    PubMed     Abstract available


  102. BESSE MC, Collercandy N, Diot E
    Gynecologic Vasculitis: Positron Emission Tomography-Computed Tomography Contribution in a Rare Localization of Giant Cell Arteritis.
    J Rheumatol. 2019;46:439.
    PubMed    


  103. BUTENDIECK RR JR, Abril A, Cortese C
    Dr. Butendieck, et al, reply.
    J Rheumatol. 2019;46:439-440.
    PubMed    


  104. SANDHU VK, Weisman MH
    Hydroxychloroquine - How Much Is Too Much?
    J Rheumatol. 2019;46:340-342.
    PubMed    


    March 2019
  105. WITCZAK BN, Hetlevik SO, Sanner H, Barth Z, et al
    Effect on Cardiac Function of Longstanding Juvenile-onset Mixed Connective Tissue Disease: A Controlled Study.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180526. doi: 10.3899/jrheum.180526.
    PubMed     Abstract available


  106. LI C, Yap DYH, Chan G, Wen YB, et al
    Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy showing Thrombotic Microangiopathy.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180773. doi: 10.3899/jrheum.180773.
    PubMed     Abstract available


  107. DUMONT A, Parienti JJ, Delmas C, Boutemy J, et al
    Factors Associated with Relapse and Dependence to Glucocorticoids in Giant-Cell Arteritis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181127. doi: 10.3899/jrheum.181127.
    PubMed     Abstract available


  108. TERRE A, Talbot A, Louvrier C, Picque JB, et al
    Monoclonal gammopathy, arthralgias, and recurrent fever syndrome: a new autoinflammatory syndrome?
    J Rheumatol. 2019 Mar 15. pii: jrheum.181204. doi: 10.3899/jrheum.181204.
    PubMed     Abstract available


  109. BANERJEE S, Quinn KA, Gribbons KB, Rosenblum JS, et al
    Effect of Treatment on Imaging, Clinical, and Serologic Assessments of Disease Activity in Large-Vessel Vasculitis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181222. doi: 10.3899/jrheum.181222.
    PubMed     Abstract available


  110. TAMAI H, Nishina N, Takeuchi T
    Pulmonary Vein Vasculitis Presenting as Multiple Pulmonary Nodules in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2019;46:323-324.
    PubMed    


  111. SHA SJ, Hou JH, Xie GT, Sun W, et al
    Improvement of outcomes in patients with lupus nephritis: management evolution in Chinese patients from 1994 to 2010.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180145. doi: 10.3899/jrheum.180145.
    PubMed     Abstract available


  112. UGARTE-GIL MF, Wojdyla D, Pons-Estel GJ, Quintana R, et al
    Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a multi-ethnic, multinational Latin-American Lupus Cohort.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180433. doi: 10.3899/jrheum.180433.
    PubMed     Abstract available


  113. SOLOMON IH, Docken WP, Padera RF
    Giant cell arteritis is not associated with varicella zoster virus in temporal artery biopsies or ascending aortic resections.
    J Rheumatol. 2019 Mar 1. pii: jrheum.180912. doi: 10.3899/jrheum.180912.
    PubMed     Abstract available


    February 2019
  114. TAO JJ, Hiraki LT, Levy DM, Silverman ED, et al
    Comparison of Sensitivities of American College of Rheumatology and Systemic Lupus International Collaborating Clinics Classification Criteria in Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 15. pii: jrheum.180337. doi: 10.3899/jrheum.180337.
    PubMed     Abstract available


  115. OTOBO TM, Conaghan PG, Maksymowych WP, van der Heijde D, et al
    Preliminary Definitions for Sacroiliac Joint Pathologies in the OMERACT Juvenile Idiopathic Arthritis MRI Score (OMERACT JAMRIS-SIJ).
    J Rheumatol. 2019 Feb 15. pii: jrheum.181115. doi: 10.3899/jrheum.181115.
    PubMed     Abstract available


  116. BARBACKI A, Petri M, Avina-Zubieta A, Alarcon GS, et al
    Fatigue Measurements in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180831. doi: 10.3899/jrheum.180831.
    PubMed     Abstract available


  117. UROWITZ MB, Su J, Gladman DD
    Atherosclerotic Vascular Events in Systemic Lupus Erythematosus - an Evolving Story.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180986. doi: 10.3899/jrheum.180986.
    PubMed     Abstract available


  118. LIU LH, Fevrier HB, Goldfien R, Hemmerling A, et al
    Understanding Non-Adherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 1. pii: jrheum.180946. doi: 10.3899/jrheum.180946.
    PubMed     Abstract available


  119. BEUKELMAN T, Nigrovic PA
    Juvenile Idiopathic Arthritis: An Idea Whose Time Has Gone?
    J Rheumatol. 2019;46:124-126.
    PubMed    


    January 2019
  120. MERAYO-CHALICO J, Barrera-Vargas A, Morales-Padilla S, Reyna-De la Garza R, et al
    Epidemiologic Profile of Erectile Dysfunction in Patients with Systemic Lupus Erythematosus: The Latin American Landscape.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180292. doi: 10.3899/jrheum.180292.
    PubMed     Abstract available


  121. WIRESTAM L, Enocsson H, Skogh T, Padyukov L, et al
    Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180713. doi: 10.3899/jrheum.180713.
    PubMed     Abstract available


  122. QUEVEDO-ABELEDO JC, Rua-Figueroa I, Sanchez-Perez H, Tejera-Segura B, et al
    Disease Damage Influences Cardiovascular Risk Reclassification Based on Carotid Ultrasound in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180881. doi: 10.3899/jrheum.180881.
    PubMed     Abstract available


  123. KOSTER MJ, Yeruva K, Crowson CS, Muratore F, et al
    Efficacy of Methotrexate in Real-world Management of Giant Cell Arteritis: A Case-control Study.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180429. doi: 10.3899/jrheum.180429.
    PubMed     Abstract available


  124. BREKKE LK, Fevang BT, Myklebust G
    Increased Incidence of Giant Cell Arteritis in Urban Areas?
    J Rheumatol. 2019 Jan 15. pii: jrheum.180714. doi: 10.3899/jrheum.180714.
    PubMed     Abstract available


  125. HOZUMI H, Fujisawa T, Nakashima R, Yasui H, et al
    Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody-positive Polymyositis/dermatomyositis-associated Interstitial Lung Disease: A Propensity Score-matched Analysis.
    J Rheumatol. 2019 Jan 15. pii: jrheum.180778. doi: 10.3899/jrheum.180778.
    PubMed     Abstract available


  126. ZHANG S, Zhang F, Li Y
    Should aPS/PT Be Incorporated into the Routine Serological Tests in the Diagnosis of Antiphospholipid Syndrome?
    J Rheumatol. 2019;46:114-116.
    PubMed    


  127. ZOHOURY N
    N. Zohoury replies.
    J Rheumatol. 2019;46:116-117.
    PubMed    


  128. ZHAO Y, Rascoff NE, Iyer RS, Thapa M, et al
    Dr. Zhao, et al, reply.
    J Rheumatol. 2019;46:113-114.
    PubMed    


  129. ROTH J
    Predictive Value of Musculoskeletal Ultrasound for Flares in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2019;46:113.
    PubMed    


    December 2018
  130. JOHNSON SR, Khanna D, Daikh D, Cervera R, et al
    Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria.
    J Rheumatol. 2018 Dec 15. pii: jrheum.180478. doi: 10.3899/jrheum.180478.
    PubMed     Abstract available


  131. VAN ROON AM, Huisman CC, van Roon AM, Zhang D, et al
    Abnormal Nailfold Capillaroscopy Is Common in Patients with Connective Tissue Disease and Associated with Abnormal Pulmonary Function Tests.
    J Rheumatol. 2018 Dec 15. pii: jrheum.180615. doi: 10.3899/jrheum.180615.
    PubMed     Abstract available


  132. HAGEN M, Englbrecht M, Haschka J, Reiser M, et al
    Cost-effective Tapering Algorithm in Rheumatoid Arthritis Patients: Combination of Multibiomarker Disease Activity Score and Autoantibody Status.
    J Rheumatol. 2018 Dec 1. pii: jrheum.180028. doi: 10.3899/jrheum.180028.
    PubMed     Abstract available


  133. SUN YS, Huang DF, Lin FC, Hsu CK, et al
    Cytomegaloviral or Pneumocystis Jiroveci Pneumonia Increases Mortality in Systemic Lupus Erythematosus Patients with Pulmonary Hemorrhage: Evidence from Bronchoalveolar Lavage Fluid.
    J Rheumatol. 2018 Dec 1. pii: jrheum.180104. doi: 10.3899/jrheum.180104.
    PubMed     Abstract available



  134. The Effect of Vitamin D Supplementation on Inflammatory and Hemostatic Markers and Disease Activity in Patients with Systemic Lupus Erythematosus: A Randomized Placebo-controlled Trial.
    J Rheumatol. 2018;45:1713.
    PubMed    


  135. GREMESE E, DE Lorenzis E, Ferraccioli GF
    Statins and Mortality in Connective Tissue Diseases: Should We Resume the Cardio-rheumatology Spirit in Our Clinics?
    J Rheumatol. 2018;45:1617-1619.
    PubMed    


    November 2018
  136. MAESHIMA K, Ishii K, Shibata H
    An Adult Fatal Case with a STAT1 Gain-of-function Mutation Associated with Multiple Autoimmune Diseases.
    J Rheumatol. 2018 Nov 15. pii: jrheum.180210. doi: 10.3899/jrheum.180210.
    PubMed     Abstract available


  137. PRADSGAARD DO, Horlyck A, Spannow AH, Heuck C, et al
    A Comparison of Radiographic Joint Space Width Measurements Versus Ultrasonographic Assessment of Cartilage Thickness in Children with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2018 Nov 15. pii: jrheum.170571. doi: 10.3899/jrheum.170571.
    PubMed     Abstract available


  138. UGOLINI R, Muratore F, Salvarani C
    Cardiac and Pulmonary Artery Involvement Detected by 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Large-vessel Giant Cell Arteritis.
    J Rheumatol. 2018;45:1603-1604.
    PubMed    


    October 2018
  139. TSELIOS K, Deeb M, Gladman DD, Harvey P, et al
    Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered?
    J Rheumatol. 2018 Oct 15. pii: jrheum.180124. doi: 10.3899/jrheum.180124.
    PubMed     Abstract available


  140. YAMADA S, Nagafuchi Y, Fujio K
    Retro-odontoid Pseudotumor Associated with Sjogren Syndrome and Systemic Lupus Erythematosus Serology.
    J Rheumatol. 2018;45:1424-1425.
    PubMed    


  141. YAP DYH, Tang C, Chan GCW, Kwan LPY, et al
    Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis.
    J Rheumatol. 2018 Oct 1. pii: jrheum.180507. doi: 10.3899/jrheum.180507.
    PubMed     Abstract available


    September 2018
  142. PESCHKEN CA, Wang Y, Abrahamowicz M, Pope J, et al
    Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Sep 15. pii: jrheum.171454. doi: 10.3899/jrheum.171454.
    PubMed     Abstract available


  143. VAN DELFT MAM, van Beest S, Kloppenburg M, Trouw LA, et al
    Presence of Autoantibodies in Erosive Hand Osteoarthritis and Association with Clinical Presentation.
    J Rheumatol. 2018 Sep 15. pii: jrheum.180256. doi: 10.3899/jrheum.180256.
    PubMed     Abstract available


  144. FAGUER S, Belliere J, Ribes D
    Complement C5-blocking Agent in Refractory Dermatomyositis.
    J Rheumatol. 2018 Sep 15. pii: jrheum.180060. doi: 10.3899/jrheum.180060.
    PubMed     Abstract available


  145. JORGE AM, Lu N, Keller SF, Rai SK, et al
    The Effect of Statin Use on Mortality in Systemic Autoimmune Rheumatic Diseases.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171389. doi: 10.3899/jrheum.171389.
    PubMed     Abstract available


  146. GARG S, Tsagaris K, Cozmuta R, Lipson A, et al
    Improving the Combination Pneumococcal Vaccination Rate in Systemic Lupus Erythematosus Patients at an Adult Rheumatology Practice.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171377. doi: 10.3899/jrheum.171377.
    PubMed     Abstract available


  147. KEELING SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, et al
    Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171459. doi: 10.3899/jrheum.171459.
    PubMed     Abstract available


  148. MITANDER A, Fei Y, Trysberg E, Mohammad M, et al
    Complement Consumption in Systemic Lupus Erythematosus Leads to Decreased Opsonophagocytosis In Vitro.
    J Rheumatol. 2018 Sep 1. pii: jrheum.171325. doi: 10.3899/jrheum.171325.
    PubMed     Abstract available


    August 2018
  149. KEELING SO, Vandermeer B, Medina J, Chatterley T, et al
    Measuring Disease Activity and Damage with Validated Metrics: A Systematic Review on Mortality and Damage in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Aug 15. pii: jrheum.171310. doi: 10.3899/jrheum.171310.
    PubMed     Abstract available


  150. VAN DIJKHUIZEN EHP, Vanoni F, Magnano GM, Magnaguagno F, et al
    Effect of the Inclusion of the Metacarpophalangeal Joints on the Wrist Magnetic Resonance Imaging Scoring System in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2018 Aug 15. pii: jrheum.171246. doi: 10.3899/jrheum.171246.
    PubMed     Abstract available


  151. HETLEVIK SO, Flato B, Aalokken TM, Lund MB, et al
    Pulmonary Manifestations and Progression of Lung Disease in Juvenile-onset Mixed Connective Tissue Disease.
    J Rheumatol. 2018 Aug 1. pii: jrheum.180019. doi: 10.3899/jrheum.180019.
    PubMed     Abstract available


  152. LIPHAUS BL, Sallum AEM, Aikawa NE, Kiss MHB, et al
    Increased Soluble Cytoplasmic Bcl-2 Protein Serum Levels and Expression and Decreased Fas Expression in Lymphocytes and Monocytes in Juvenile Dermatomyositis.
    J Rheumatol. 2018 Aug 1. pii: jrheum.171248. doi: 10.3899/jrheum.171248.
    PubMed     Abstract available


  153. TSELIOS K, Gladman DD, Harvey P, Akhtari S, et al
    Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials?
    J Rheumatol. 2018 Aug 1. pii: jrheum.171436. doi: 10.3899/jrheum.171436.
    PubMed     Abstract available


  154. KEELING SO, Bissonauth A, Bernatsky S, Vandermeer B, et al
    Practice Variations in the Diagnosis, Monitoring, and Treatment of Systemic Lupus Erythematosus in Canada.
    J Rheumatol. 2018 Aug 1. pii: jrheum.171307. doi: 10.3899/jrheum.171307.
    PubMed     Abstract available


  155. BUTENDIECK RR JR, Abril A, Cortese C
    Unusual Presentation of Giant Cell Arteritis in 2 Patients: Uterine Involvement.
    J Rheumatol. 2018;45:1201-1202.
    PubMed    


    July 2018
  156. GARNIER C, Ribes D, Chauveau D, Huart A, et al
    Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.
    J Rheumatol. 2018 Jul 15. pii: jrheum.180310. doi: 10.3899/jrheum.180310.
    PubMed     Abstract available


  157. YUE C, Su J, Gao R, Wen Y, et al
    Characteristics and Outcomes of Patients with Systemic Lupus Erythematosus-associated Thrombotic Microangiopathy, and Their Acquired ADAMTS13 Inhibitor Profiles.
    J Rheumatol. 2018 Jul 15. pii: jrheum.170811. doi: 10.3899/jrheum.170811.
    PubMed     Abstract available


  158. ZAMPELI E, Kalogirou EM, Piperi E, Mavragani CP, et al
    Tongue Atrophy in Sjogren Syndrome Patients with Mucosa-associated Lymphoid Tissue Lymphoma: Autoimmune Epithelitis beyond the Epithelial Cells of Salivary Glands?
    J Rheumatol. 2018 Jul 15. pii: jrheum.180101. doi: 10.3899/jrheum.180101.
    PubMed     Abstract available


  159. CANTI V, Del Rosso S, Tonello M, Luciano R, et al
    Antiphosphatidylserine/prothrombin Antibodies in Antiphospholipid Syndrome with Intrauterine Growth Restriction and Preeclampsia.
    J Rheumatol. 2018 Jul 15. pii: jrheum.170751. doi: 10.3899/jrheum.170751.
    PubMed     Abstract available


  160. BATU ED, Kosukcu C, Taskiran E, Sahin S, et al
    Whole Exome Sequencing in Early-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jul 15. pii: jrheum.171358. doi: 10.3899/jrheum.171358.
    PubMed     Abstract available


  161. MCDONALD EG, Bissonette L, Ensworth S, Dayan N, et al
    Monitoring of Systemic Lupus Erythematosus Pregnancies: A Systematic Literature Review.
    J Rheumatol. 2018 Jul 15. pii: jrheum.171023. doi: 10.3899/jrheum.171023.
    PubMed     Abstract available


  162. EUDY AM, Siega-Riz AM, Engel SM, Franceschini N, et al
    Preconceptional Cardiovascular Health and Pregnancy Outcomes in Women with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jul 15. pii: jrheum.171066. doi: 10.3899/jrheum.171066.
    PubMed     Abstract available


  163. ALHARBI S, Ahmad Z, Bookman AA, Touma Z, et al
    Epidemiology and Survival of Systemic Sclerosis-Systemic Lupus Erythematosus Overlap Syndrome.
    J Rheumatol. 2018 Jul 15. pii: jrheum.170953. doi: 10.3899/jrheum.170953.
    PubMed     Abstract available


  164. HUSSEIN S, Suitner M, Beland-Bonenfant S, Baril-Dionne A, et al
    Monitoring of Osteonecrosis in Systemic Lupus Erythematosus Patients: A Systematic Review and Metaanalysis.
    J Rheumatol. 2018 Jul 1. pii: jrheum.170837. doi: 10.3899/jrheum.170837.
    PubMed     Abstract available


  165. SCHAFER VS, Chrysidis S, Dejaco C, Duftner C, et al
    Assessing Vasculitis in Giant Cell Arteritis by Ultrasound: Results of OMERACT Patient-based Reliability Exercises.
    J Rheumatol. 2018 Jul 1. pii: jrheum.171428. doi: 10.3899/jrheum.171428.
    PubMed     Abstract available


  166. BAICUS C
    At What Age Was Systemic Lupus Erythematosus Diagnosed in This Cohort?
    J Rheumatol. 2018;45:1070.
    PubMed    


    June 2018
  167. XIE L, Xu J
    Role of MiR-98 and Its Underlying Mechanisms in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 15. pii: jrheum.171290. doi: 10.3899/jrheum.171290.
    PubMed     Abstract available


  168. TROLDBORG A, Thiel S, Trendelenburg M, Friebus-Kardash J, et al
    The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 15. pii: jrheum.171033. doi: 10.3899/jrheum.171033.
    PubMed     Abstract available


  169. ZAMPELI E, Skopouli FN, Moutsopoulos HM
    Polyserositis in a Patient with Active Systemic Lupus Erythematosus: A Case of Pseudo-pseudo Meigs Syndrome.
    J Rheumatol. 2018;45:877-878.
    PubMed    


  170. FONGAUFIER C, Guffroy A, Lutz JC
    Tongue and Scalp Necrosis: Simultaneous Initial Complications Revealing Giant Cell Arteritis.
    J Rheumatol. 2018;45:873-874.
    PubMed    


  171. LABRADOR-HORRILLO M, Selva-O'Callaghan A
    Cancer-associated Dermatomyositis: Does the PD-1 Checkpoint Pathway Play a Role?
    J Rheumatol. 2018;45:731-732.
    PubMed    


  172. TSELIOS K, Gladman DD, Touma Z, Su J, et al
    Monophasic Disease Course in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jun 1. pii: jrheum.171319. doi: 10.3899/jrheum.171319.
    PubMed     Abstract available


  173. GUDERUD K, Maehlen MT, Nordang GBN, Viken MK, et al
    Lack of Association among Peptidyl Arginine Deiminase Type 4 Autoantibodies, PADI4 Polymorphisms, and Clinical Characteristics in Rheumatoid Arthritis.
    J Rheumatol. 2018 Jun 1. pii: jrheum.170769. doi: 10.3899/jrheum.170769.
    PubMed     Abstract available


    April 2018
  174. RAISSI TC, Hewson C, Pope JE
    Repeat Testing of Antibodies and Complements in Systemic Lupus Erythematosus: When Is It Enough?
    J Rheumatol. 2018 Apr 15. pii: jrheum.161365. doi: 10.3899/jrheum.161365.
    PubMed     Abstract available


  175. NANGIT A, Lin C, Ishimori ML, Spiegel BMR, et al
    Causes and Predictors of Early Hospital Readmission in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170176. doi: 10.3899/jrheum.170176.
    PubMed     Abstract available


  176. TANHA N, Hansen RB, Nielsen CT, Faurschou M, et al
    Clinical and Serological Associations with the Development of Incident Proteinuria in Danish Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170933. doi: 10.3899/jrheum.170933.
    PubMed     Abstract available


  177. KAWASUMI H, Katsumata Y, Nishino A, Hirahara S, et al
    Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody-positive Cases.
    J Rheumatol. 2018 Apr 15. pii: jrheum.170997. doi: 10.3899/jrheum.170997.
    PubMed     Abstract available


  178. VEGA-MORALES D, Hernandez-Galarza IJ, Galarza-Delgado DA
    Causes of Hospital Mortality in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus in a University Hospital: 1998-2015 Analysis.
    J Rheumatol. 2018;45:583-584.
    PubMed    


  179. ZHAO Y, Rascoff NE, Iyer RS, Thapa M, et al
    Flares of Disease in Children with Clinically Inactive Juvenile Idiopathic Arthritis Were Not Correlated with Ultrasound Findings.
    J Rheumatol. 2018 Apr 1. pii: jrheum.170681. doi: 10.3899/jrheum.170681.
    PubMed     Abstract available


    March 2018
  180. ROMERO-DIAZ J, Acosta-Hernandez RI, Criales-Vera S, Kimura-Hayama E, et al
    Asymptomatic Coronary Artery Calcifications in Men with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170330. doi: 10.3899/jrheum.170330.
    PubMed     Abstract available


  181. YANG J, Yang X, Yang J, Li M, et al
    Hydroxychloroquine Inhibits the Differentiation of Th17 Cells in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170737. doi: 10.3899/jrheum.170737.
    PubMed     Abstract available


  182. LIOZON E, de Boysson H, Dalmay F, Gondran G, et al
    Development of Giant Cell Arteritis after Treating Polymyalgia or Peripheral Arthritis: A Retrospective Case-control Study.
    J Rheumatol. 2018 Mar 15. pii: jrheum.170455. doi: 10.3899/jrheum.170455.
    PubMed     Abstract available


  183. FRITZLER MJ, Choi MY, Mahler M
    The Antinuclear Antibody Test in the Diagnosis of Antisynthetase Syndrome and Other Autoimmune Myopathies.
    J Rheumatol. 2018;45:444-445.
    PubMed    


  184. BHANSING KJ, VAN Rosmalen MH, VAN Engelen BG, VAN Riel PL, et al
    Ultrasound: A Potential Tool for Detecting of Fasciitis in Dermatomyositis and Polymyositis.
    J Rheumatol. 2018;45:441-442.
    PubMed    


  185. TIDWELL WJ, Callen JP
    Koebner Phenomenon in Juvenile Dermatomyositis.
    J Rheumatol. 2018;45:437.
    PubMed    


  186. DAVIDSON JE, Fu Q, Ji B, Rao S, et al
    Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis.
    J Rheumatol. 2018 Mar 1. pii: jrheum.161554. doi: 10.3899/jrheum.161554.
    PubMed     Abstract available


    February 2018
  187. YUE C, Li G, Wen Y, Li X, et al
    Early Renin-angiotensin System Blockade Improved Short-term and Longterm Renal Outcomes in Systemic Lupus Erythematosus Patients with Antiphospholipid-associated Nephropathy.
    J Rheumatol. 2018 Feb 15. pii: jrheum.170561. doi: 10.3899/jrheum.170561.
    PubMed     Abstract available


  188. CAI F, Han F, Wang H, Han H, et al
    The Crescentic Implication of Renal Outcomes in Proliferative Lupus Nephritis.
    J Rheumatol. 2018 Feb 15. pii: jrheum.170553. doi: 10.3899/jrheum.170553.
    PubMed     Abstract available


  189. KASTURI S, Szymonifka J, Burket JC, Berman JR, et al
    Feasibility, Validity, and Reliability of the 10-item Patient Reported Outcomes Measurement Information System Global Health Short Form in Outpatients with Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Feb 1. pii: jrheum.170590. doi: 10.3899/jrheum.170590.
    PubMed     Abstract available


  190. CHEN H, Peng Q, Yang H, Yin L, et al
    Increased Levels of Soluble Programmed Death Ligand 1 Associate with Malignancy in Patients with Dermatomyositis.
    J Rheumatol. 2018 Feb 1. pii: jrheum.170544. doi: 10.3899/jrheum.170544.
    PubMed     Abstract available


  191. ALEXANDERSON H, Regardt M, Ottosson C, Alemo Munters L, et al
    Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective Study.
    J Rheumatol. 2018 Feb 1. pii: jrheum.161183. doi: 10.3899/jrheum.161183.
    PubMed     Abstract available


  192. LUCAS S, Chang WL, Merien F
    Prevalence and Clinical Significance of Anti-DFS70 in Antinuclear Antibody (ANA)-positive Patients Undergoing Routine ANA Testing in a New Zealand Public Hospital.
    J Rheumatol. 2018;45:289-291.
    PubMed    


  193. CHEN YH, Lu CC, Chen HC
    Candida albicans Pyomyositis in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2018;45:286-287.
    PubMed    


    January 2018
  194. BERNATSKY S, Ramsey-Goldman R, Petri M, Urowitz MB, et al
    Smoking Is the Most Significant Modifiable Lung Cancer Risk Factor in Systemic Lupus Erythematosus.
    J Rheumatol. 2018 Jan 15. pii: jrheum.170652. doi: 10.3899/jrheum.170652.
    PubMed     Abstract available


    December 2017
  195. YEUNG Y, Barra LJ
    Cardiovascular Risk Prevention in a Canadian Population of Patients with Giant Cell Arteritis.
    J Rheumatol. 2017;44:1942-1943.
    PubMed    


  196. NAVRATIL M, Ivkovic Jurekovic I
    Chloroquine Toxicity Misdiagnosed as Fabry Disease Associated with Systemic Lupus Erythematosus and Hashimoto Thyroiditis.
    J Rheumatol. 2017;44:1940.
    PubMed    


  197. BLOCKMANS D
    Fluorodeoxyglucose Positron Emission Tomography for Giant Cell Arteritis.
    J Rheumatol. 2017;44:1763-1764.
    PubMed    


    November 2017
  198. PAKCHOTANON R, Gladman DD, Su J, Urowitz MB, et al
    More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170645. doi: 10.3899/jrheum.170645.
    PubMed     Abstract available


  199. RICHTER JG, Muth T, Li J, Brinks R, et al
    Elevated Psychosocial Stress at Work in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    J Rheumatol. 2017 Nov 15. pii: jrheum.170233. doi: 10.3899/jrheum.170233.
    PubMed     Abstract available


  200. CHEN HL, Shen LJ, Hsu PN, Shen CY, et al
    Cumulative Burden of Glucocorticoid-related Adverse Events in Patients with Systemic Lupus Erythematosus: Findings from a 12-year Longitudinal Study.
    J Rheumatol. 2017 Nov 15. pii: jrheum.160214. doi: 10.3899/jrheum.160214.
    PubMed     Abstract available


  201. TSELIOS K, Gladman DD, Su J, Ace O, et al
    Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study.
    J Rheumatol. 2017 Nov 1. pii: jrheum.161121. doi: 10.3899/jrheum.161121.
    PubMed     Abstract available


    October 2017
  202. VITIELLO G, Cammelli D
    Large-vessel Involvement and Varicella Zoster Virus Vasculopathy in Giant Cell Arteritis-related Stroke: Something to Keep an Eye On.
    J Rheumatol. 2017;44:1566.
    PubMed    


  203. CHEN Y, Liu J
    What is the Definition of the Anticytoplasmic Autoantibody?
    J Rheumatol. 2017;44:1564.
    PubMed    


    September 2017
  204. ROSSIDES M, Simard JF, Svenungsson E, von Euler M, et al
    Mortality and Functionality after Stroke in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170241. doi: 10.3899/jrheum.170241.
    PubMed     Abstract available


  205. CLIFFORD AH, Murphy EM, Burrell SC, Bligh MP, et al
    Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170138. doi: 10.3899/jrheum.170138.
    PubMed     Abstract available


  206. BONEPARTH A, Radhakrishna SM, Greenbaum LA, Yen E, et al
    Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists.
    J Rheumatol. 2017 Sep 15. pii: jrheum.170502. doi: 10.3899/jrheum.170502.
    PubMed     Abstract available



  207. Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
    J Rheumatol. 2017;44:1417.
    PubMed    


  208. KUMTHEKAR A, Danve A, Deodhar A
    Use of Belimumab throughout 2 Consecutive Pregnancies in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2017;44:1416-1417.
    PubMed    


  209. NANTES SG, Su J, Dhaliwal A, Colosimo K, et al
    Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Sep 1. pii: jrheum.161125. doi: 10.3899/jrheum.161125.
    PubMed     Abstract available


  210. ZOHOURY N, Bertolaccini ML, Rodriguez-Garcia JL, Shums Z, et al
    Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid Antibodies.
    J Rheumatol. 2017 Sep 1. pii: jrheum.170044. doi: 10.3899/jrheum.170044.
    PubMed     Abstract available


    August 2017
  211. BERNATSKY S, Clarke AE, Niaki OZ, Labrecque J, et al
    Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Aug 1. pii: jrheum.170179. doi: 10.3899/jrheum.170179.
    PubMed     Abstract available


    July 2017
  212. CHEN Z, Wang Y, Kuwana M, Xu X, et al
    HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis.
    J Rheumatol. 2017 Jul 15. pii: jrheum.170165. doi: 10.3899/jrheum.170165.
    PubMed     Abstract available


  213. HOZUMI H, Fujisawa T, Enomoto N, Nakashima R, et al
    Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.
    J Rheumatol. 2017 Jul 15. pii: jrheum.170373. doi: 10.3899/jrheum.170373.
    PubMed     Abstract available


  214. NAGASHIMA T, Iwamoto M, Minota S
    Gottron Sign with Ulceration Is Not a Poor Prognostic Factor in Patients with Dermatomyositis and Interstitial Lung Disease.
    J Rheumatol. 2017;44:1099-1100.
    PubMed    


  215. YAP DYH, Tang C, Ma MKM, Mok MMY, et al
    Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years.
    J Rheumatol. 2017 Jul 1. pii: jrheum.170226. doi: 10.3899/jrheum.170226.
    PubMed     Abstract available


    June 2017
  216. BRUNNER HI, Bennett MR, Gulati G, Abulaban K, et al
    Urine Biomarkers to Predict Response to Lupus Nephritis Therapy in Children and Young Adults.
    J Rheumatol. 2017 Jun 15. pii: jrheum.161128. doi: 10.3899/jrheum.161128.
    PubMed     Abstract available


  217. GU K, Gladman DD, Su J, Urowitz MB, et al
    Hospitalizations in Patients with Systemic Lupus Erythematosus in an Academic Health Science Center.
    J Rheumatol. 2017 Jun 15. pii: jrheum.170072. doi: 10.3899/jrheum.170072.
    PubMed     Abstract available


  218. KURTZMAN DJB, Weinblatt M, Vleugels RA
    Antimelanoma Differentiation-associated Gene 5 Dermatomyositis.
    J Rheumatol. 2017;44:850-851.
    PubMed    


  219. TARABORELLI M, Reggia R, Dall'Ara F, Fredi M, et al
    Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study.
    J Rheumatol. 2017 Jun 1. pii: jrheum.161364. doi: 10.3899/jrheum.161364.
    PubMed     Abstract available


  220. HEMKE R, Tzaribachev N, Nusman CM, van Rossum MAJ, et al
    Magnetic Resonance Imaging (MRI) of the Knee as an Outcome Measure in Juvenile Idiopathic Arthritis: An OMERACT Reliability Study on MRI Scales.
    J Rheumatol. 2017 Jun 1. pii: jrheum.160821. doi: 10.3899/jrheum.160821.
    PubMed     Abstract available


    May 2017
  221. QUARTUCCIO L, Baldini C, Priori R, Bartoloni E, et al
    Cryoglobulinemia in Sjogren Syndrome: A Disease Subset that Links Higher Systemic Disease Activity, Autoimmunity, and Local B Cell Proliferation in Mucosa-associated Lymphoid Tissue.
    J Rheumatol. 2017 May 15. pii: jrheum.161465. doi: 10.3899/jrheum.161465.
    PubMed     Abstract available


  222. FASANO S, Pierro L, Pantano I, Iudici M, et al
    Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2017 May 15. pii: jrheum.161351. doi: 10.3899/jrheum.161351.
    PubMed     Abstract available


  223. NAKABO S, Yoshifuji H, Hashimoto M, Imura Y, et al
    Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.
    J Rheumatol. 2017 May 15. pii: jrheum.161432. doi: 10.3899/jrheum.161432.
    PubMed     Abstract available


  224. SHI J, Li S, Yang H, Zhang Y, et al
    Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
    J Rheumatol. 2017 May 1. pii: jrheum.161480. doi: 10.3899/jrheum.161480.
    PubMed     Abstract available


  225. LE PENDU C, Meignin V, Gonzalez-Chiappe S, Hij A, et al
    Poor Predictive Value of Isolated Adventitial and Periadventitial Infiltrates in Temporal Artery Biopsies for Diagnosis of Giant Cell Arteritis.
    J Rheumatol. 2017 May 1. pii: jrheum.170061. doi: 10.3899/jrheum.170061.
    PubMed     Abstract available


  226. KOSTER MJ, Achenbach SJ, Crowson CS, Maradit-Kremers H, et al
    Healthcare Use and Direct Cost of Giant Cell Arteritis: A Population-based Study.
    J Rheumatol. 2017 May 1. pii: jrheum.161516. doi: 10.3899/jrheum.161516.
    PubMed     Abstract available


  227. MURO Y, Iwata N, Tanaka Y, Kodera M, et al
    Anti-dense Fine Speckled 70 Autoantibodies in Japanese Children with Dermatomyositis, Localized Scleroderma, and Idiopathic Arthritis with Iridocyclitis.
    J Rheumatol. 2017;44:711-712.
    PubMed    


  228. GENEST G, Laskin CA
    Safety and Efficacy of in Vitro Fertilization in Women with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
    J Rheumatol. 2017;44:547-549.
    PubMed    


    April 2017
  229. KASTURI S, Szymonifka J, Burket JC, Berman JR, et al
    Validity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Apr 15. pii: jrheum.161202. doi: 10.3899/jrheum.161202.
    PubMed     Abstract available


  230. SIMONINI G, Bracaglia C, Cattalini M, Taddio A, et al
    Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161336. doi: 10.3899/jrheum.161336.
    PubMed     Abstract available


  231. BERNTSEN KS, Tollisen A, Schwartz T, Kirkhus E, et al
    Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement.
    J Rheumatol. 2017 Apr 1. pii: jrheum.160997. doi: 10.3899/jrheum.160997.
    PubMed     Abstract available


  232. GUERRA F, Gelardi C, Capucci A, Gabrielli A, et al
    Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161311. doi: 10.3899/jrheum.161311.
    PubMed     Abstract available


  233. YANG N, Bhattacharyya S, Weinblatt M
    Refractory Syndrome of Inappropriate Secretion of Antidiuretic Hormone in Systemic Lupus Erythematosus-associated Hypophysitis.
    J Rheumatol. 2017;44:541-542.
    PubMed    


  234. NIHTYANOVA SI, Denton CP
    Scleroderma Lung Involvement, Autoantibodies, and Outcome Prediction: The Confounding Effect of Time.
    J Rheumatol. 2017;44:404-406.
    PubMed    


    March 2017
  235. ZISMAN D, Gladman DD, Stoll ML, Strand V, et al
    The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.
    J Rheumatol. 2017;44:342-351.
    PubMed     Abstract available


  236. HORTON DB, Onel KB, Beukelman T, Ringold S, et al
    Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.
    J Rheumatol. 2017;44:352-360.
    PubMed     Abstract available


  237. WARD TM, Beebe DW, Chen ML, Landis CA, et al
    Sleep Disturbances and Neurobehavioral Performance in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2017;44:361-367.
    PubMed     Abstract available


  238. VAN DAALEN EE, Rahmattulla C, Wolterbeek R, Bruijn JA, et al
    Incidence of Malignancy Prior to Antineutrophil Cytoplasmic Antibody-associated Vasculitis Compared to the General Population.
    J Rheumatol. 2017;44:314-318.
    PubMed     Abstract available


  239. AESCHLIMANN FA, Angst F, Hofer KD, Cannizzaro Schneider E, et al
    Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort Study.
    J Rheumatol. 2017;44:334-341.
    PubMed     Abstract available


  240. STOUSTRUP P, Twilt M, Spiegel L, Kristensen KD, et al
    Clinical Orofacial Examination in Juvenile Idiopathic Arthritis: International Consensus-based Recommendations for Monitoring Patients in Clinical Practice and Research Studies.
    J Rheumatol. 2017;44:326-333.
    PubMed     Abstract available


    February 2017
  241. GUZMAN J, Henrey A, Loughin T, Berard RA, et al
    Predicting Which Children with Juvenile Idiopathic Arthritis Will Have a Severe Disease Course: Results from the ReACCh-Out Cohort.
    J Rheumatol. 2017;44:230-240.
    PubMed     Abstract available


  242. FURUTA S, Chaudhry AN, Arimura Y, Dobashi H, et al
    Comparison of the Phenotype and Outcome of Granulomatosis with Polyangiitis Between UK and Japanese Cohorts.
    J Rheumatol. 2017;44:216-222.
    PubMed     Abstract available


    January 2017
  243. THOMAS G, Cohen Aubart F, Chiche L, Haroche J, et al
    Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients.
    J Rheumatol. 2017;44:24-32.
    PubMed     Abstract available


    June 2016
  244. NUSMAN CM, Rosendahl K, Maas M
    MRI Protocol for the Assessment of Juvenile Idiopathic Arthritis of the Wrist: Recommendations from the OMERACT MRI in JIA Working Group and Health-e-Child.
    J Rheumatol. 2016;43:1257-8.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: